Diamyd Medical will receive USD 1.75 million in expanded collaboration support from Breakthrough T1D (formerly JDRF), the world's leading Type 1 Diabetes ...
Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...
Diamyd Medical will receive USD 1.75 million in expanded collaboration support from Breakthrough T1D (formerly JDRF), the world's leading Type 1 Diabetes research and advocacy organization, in support ...
A team from Osaka University has developed scSPOT, a new technique that reveals how immune cells called Tregs simultaneously ...